Connect with us

Hi, what are you looking for?

Jewish Business News


Court Gives Teva Green Light For Generic Arthritis Drug

A federal judge in Virginia ruled that the patent for Pfizer’s Celebrex expires in May.


A US federal judge in Virginia has given Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) the go-ahead to begin marketing a generic version of arthritis treatment Celebrex after ruling that the drug’s patent expires in May. Pfizer Inc. (NYSE: PFE) had been seeking to extend the patent of the blockbuster drug, which has annual sales of $3 billion, through to December 2015.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.

Published by Globes [online], Israel business news –



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.